New Directions in Depression Treatment: Hopes, Challenges, and the Future of Integrated Psychiatry
Main Article Content
Abstract
This article presents new directions in the treatment of depression, with particular emphasis on the development of the integrated approach in psychiatry. It discusses contemporary innovations in both psychotherapy and pharmacotherapy, including digital therapy, ketamine-assisted treatment, and the psychotherapeutic use of psychedelics. The article highlights the growing importance of holistic and humanistic approaches—especially Gestalt therapy—and the potential to combine technological advancements with the relational depth of traditional psychotherapy. The aim of the study is to establish a conceptual framework for understanding the future of mental health interventions in the context of increasing social and emotional complexity.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
With the receipt of the article by the Editorial Board of the Cakrawala: Jurnal Ilmu Pendidikan and it was decided to be published, then the copyright regarding the article will be diverted to Cakrawala: Jurnal Ilmu Pendidikan.
Cakrawala: Jurnal Ilmu Pendidikan hold the copyright regarding all the published articles and has the right to multiply and distribute the article under Creative Commons Attribution-NonCommercial 4.0 International License.
A copyright transfer from the author to the journal is done by filling out the copyright transfer form by the author.
Copyright Transfer Letter: Download
Creative Commons Attribution-NonCommercial 4.0 International License
References
Alfonsi, V., Scarpelli, S., D'Atri, A., Stella, G., & De Gennaro, L. (2020). Later school start time: The impact of sleep on academic performance and health in the adolescent population. International Journal of Environmental Research and Public Health, 17(7), 2574. https://doi.org/10.3390/ijerph17072574
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
Andrews, G., Basu, A., Cuijpers, P., Craske, M. G., McEvoy, P., English, C., ... & Newby, J. M. (2018). Computer therapy for the anxiety and depression disorders is effective, acceptable and practical health care: An updated meta-analysis. Journal of Anxiety Disorders, 55, 70–78. https://doi.org/10.1016/j.janxdis.2018.01.001
Baumel, A., Muench, F., Edan, S., & Kane, J. M. (2019). Objective User Engagement With Mental Health Apps: Systematic Search and Panel-Based Usage Analysis. Journal of Medical Internet Research, 21(9), e14567. https://doi.org/10.2196/14567
Cain, D. J. (2010). Person-Centered Psychotherapies. Washington, DC: American Psychological Association.
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., ... & Nutt, D. J. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry, 3(7), 619–627. https://doi.org/10.1016/S2215-0366(16)30065-7
Carlbring, P., Andersson, G., Cuijpers, P., Riper, H., & Hedman-Lagerlöf, E. (2018). Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: An updated systematic review and meta-analysis. Cognitive Behaviour Therapy, 47(1), 1–18. https://doi.org/10.1080/16506073.2017.1401115
Cooper, M. (2009). Existential therapies: Contributions to a pluralistic practice. Journal of Contemporary Psychotherapy, 39(2), 103–115. https://doi.org/10.1007/s10879-008-9109-6
Cuijpers, P., Karyotaki, E., Reijnders, M., & Purgato, M. (2020). Meta-analyses and mega-analyses of the effectiveness of digital health interventions for mental health. World Psychiatry, 19(3), 337–338. https://doi.org/10.1002/wps.20784
Daly, E. J., Trivedi, M. H., Janik, A., Li, H., Zhang, Y., Li, X., ... & Drevets, W. C. (2019). Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression. JAMA Psychiatry, 76(9), 893–903. https://doi.org/10.1001/jamapsychiatry.2019.1189
Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., & Griffiths, R. R. (2021). Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry, 78(5), 481–489. https://doi.org/10.1001/jamapsychiatry.2020.3285
Dimidjian, S., Barrera, M., Martell, C., Muñoz, R. F., & Lewinsohn, P. M. (2011). The origins and current status of behavioral activation treatments for depression. Annual Review of Clinical Psychology, 7, 1–38. https://doi.org/10.1146/annurev-clinpsy-032210-104535
Elliott, R., Watson, J., Greenberg, L. S., Timulak, L., & Freire, E. (2013). Research on humanistic–experiential psychotherapies. In M. J. Lambert (Ed.), Bergin and Garfield's handbook of psychotherapy and behavior change (6th ed., pp. 495–538). New York: Wiley.
Engel, G. L. (1980). The clinical application of the biopsychosocial model. The American Journal of Psychiatry, 137(5), 535–544. https://doi.org/10.1176/ajp.137.5.535
FDA. (2019). FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic. Retrieved from https://www.fda.gov
Firth, J., Solmi, M., Wootton, R. E., Vancampfort, D., Schuch, F. B., Hoare, E., ... & Stubbs, B. (2019). A meta-review of “lifestyle psychiatry”: The role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders. World Psychiatry, 18(3), 308–328. https://doi.org/10.1002/wps.20672
Fitzpatrick, K. K., Darcy, A., & Vierhile, M. (2017). Delivering Cognitive Behavior Therapy to Young Adults With Symptoms of Depression and Anxiety Using a Fully Automated Conversational Agent (Woebot): A Randomized Controlled Trial. JMIR Mental Health, 4(2), e19. https://doi.org/10.2196/mental.7785
Francesetti, G. (2013). Depression and the Body in Gestalt Therapy. Milano: FrancoAngeli.
Griffiths, R. R., Richards, W. A., Johnson, M. W., McCann, U., & Jesse, R. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology, 30(12), 1181–1197. https://doi.org/10.1177/0269881116675513
Inkster, B., Sarda, S., & Subramanian, V. (2018). An Empathy-Driven, Conversational Artificial Intelligence Agent (Wysa) for Digital Mental Well-Being: Real-World Data Evaluation Mixed-Methods Study. JMIR mHealth and uHealth, 6(11), e12106. https://doi.org/10.2196/12106
Insel, T. R. (2017). Digital phenotyping: Technology for a new science of behavior. JAMA, 318(13), 1215–1216. https://doi.org/10.1001/jama.2017.11295
Jacka, F. N., O’Neil, A., Opie, R., Itsiopoulos, C., Cotton, S., Mohebbi, M., ... & Berk, M. (2017). A randomised controlled trial of dietary improvement for adults with major depression (the “SMILES” trial). BMC Medicine, 15(1), 23. https://doi.org/10.1186/s12916-017-0791-y
Kendler, K. S. (2012). The dappled nature of causes of psychiatric illness: Replacing the organic–functional/hardware–software dichotomy with empirically based pluralism. Molecular Psychiatry, 17(4), 377–388. https://doi.org/10.1038/mp.2011.182
Miller, R. B., Wampold, B. E., & Varhely, K. (2017). The therapist factor: Implications for training and practice. Psychotherapy, 54(4), 369–375. https://doi.org/10.1037/pst0000121
Mohr, D. C., Weingardt, K. R., Reddy, M., & Schueller, S. M. (2017). Three problems with current digital mental health research... and three things we can do about it. Psychiatric Services, 68(5), 427–429. https://doi.org/10.1176/appi.ps.201600541
Norcross, J. C., & Goldfried, M. R. (2019). Handbook of psychotherapy integration (3rd ed.). New York: Oxford University Press.
Perls, F., Hefferline, R., & Goodman, P. (1951). Gestalt Therapy: Excitement and Growth in the Human Personality. New York: Julian Press.
Pincus, H. A., Pechura, C. M., Elinson, L., & Pettit, A. R. (2007). Depression in primary care: Linking clinical and systems strategies. General Hospital Psychiatry, 23(6), 311–318. https://doi.org/10.1016/S0163-8343(01)00157-1
Popova, V., Daly, E. J., Trivedi, M., Cooper, K., Lane, R., Lim, P., ... & Manji, H. (2019). Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. American Journal of Psychiatry, 176(6), 428–438. https://doi.org/10.1176/appi.ajp.2019.19020172
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163(11), 1905–1917. https://doi.org/10.1176/ajp.2006.163.11.1905
Schuch, F. B., Vancampfort, D., Richards, J., Rosenbaum, S., Ward, P. B., & Stubbs, B. (2016). Exercise as a treatment for depression: A meta-analysis adjusting for publication bias. Journal of Psychiatric Research, 77, 42–51. https://doi.org/10.1016/j.jpsychires.2016.02.023
Short, B., Fong, J., Galvez, V., Shelker, W., & Loo, C. K. (2018). Side-effects associated with ketamine use in depression: a systematic review. The Lancet Psychiatry, 5(1), 65–78. https://doi.org/10.1016/S2215-0366(17)30272-9
World Health Organization. (2019). International Classification of Diseases 10th Revision (ICD-10): Classification of Mental and Behavioural Disorders. Geneva: WHO.
World Health Organization. (2021). Depression. Retrieved from https://www.who.int/news-room/fact-sheets/detail/depression
World Health Organization. (2022). ICD-11 for Mortality and Morbidity Statistics: Mental, behavioural or neurodevelopmental disorders. Geneva: WHO.